Mark William Lowdell - Jul 7, 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Scientific Officer
Signature
/s/ Mark William Lowdell
Stock symbol
INMB
Transactions as of
Jul 7, 2021
Transactions value $
-$604,706
Form type
4
Date filed
7/9/2021, 04:06 PM
Next filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Sale -$117K -5.85K -0.39% $20.02 1.5M Jul 7, 2021 Direct F1, F2
transaction INMB Common Stock Sale -$488K -24.2K -1.61% $20.19 1.48M Jul 8, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.48, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.